During a recent meeting with the American Society of Anesthesiologists, the Office of the National Coordinator acknowledged that Stage 1 meaningful use requirements will not be modified for any specialty including anesthesiologists, though specialty-specific needs may be addressed in Stage…
Anesthesia
The Connecticut Medical Examining Board has fined a Glastonbury physician for administering an anesthetic to the wrong surgical site, according to a Hartford Courant report.
Researchers at San Francisco General Hospital recently published a study that found patients on mechanical ventilation required lower doses of sedatives when they listened to classical music, according to an Anesthesiology News report.
Anesthesia & Analgesia, the official journal of the International Anesthesia Research Society, has reported continued increase in the journal's impact factor, the rating of academic and scientific journals tracked and published annually by Thomson Reuters.
A study by researchers at the University of Colorado in Aurora found that propofol scheduling did not change how providers practiced, according to an Anesthesiology News report.
Advertisement
Mark J. Lema, MD, PhD, professor and chair of the department of anesthesiology at the University of Buffalo (N.Y.), will receive the American Society of Anesthesiologists' Distinguished Service award, the organization's highest tribute for service and achievement.
When asked why he robbed banks, Willie Sutton responded, "Because that’s where the money is."
New guidelines from the American Society of Anesthesiologists, which went into effect July 1, call for anesthesiologists to monitor exhaled carbon dioxide in lower levels of sedation than was previously required, according to a Benzinga report.
Approximately 99.5 percent of community hospitals reported experiencing at least one drug shortage in the past six months, according to a survey released by the American Hospital Association, reported in the Wall Street Journal.
The American Society of Anesthesiologists has signed a regulatory comment letter to the Department of Justice, recommending they review DEA regulations involving quotas of controlled substances.